G

Guobang Pharma Ltd
SSE:605507

Watchlist Manager
Guobang Pharma Ltd
SSE:605507
Watchlist
Price: 21.27 CNY -3.23% Market Closed
Market Cap: 11.8B CNY
Have any thoughts about
Guobang Pharma Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Guobang Pharma Ltd stock under the Base Case scenario is 34.07 CNY. Compared to the current market price of 21.27 CNY, Guobang Pharma Ltd is Undervalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
34.07 CNY
Undervaluation 38%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation Backtest
Guobang Pharma Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Guobang Pharma Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Guobang Pharma Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Guobang Pharma Ltd

Provide an overview of the primary business activities
of Guobang Pharma Ltd.

What unique competitive advantages
does Guobang Pharma Ltd hold over its rivals?

What risks and challenges
does Guobang Pharma Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Guobang Pharma Ltd.

Provide P/S
for Guobang Pharma Ltd.

Provide P/E
for Guobang Pharma Ltd.

Provide P/OCF
for Guobang Pharma Ltd.

Provide P/FCFE
for Guobang Pharma Ltd.

Provide P/B
for Guobang Pharma Ltd.

Provide EV/S
for Guobang Pharma Ltd.

Provide EV/GP
for Guobang Pharma Ltd.

Provide EV/EBITDA
for Guobang Pharma Ltd.

Provide EV/EBIT
for Guobang Pharma Ltd.

Provide EV/OCF
for Guobang Pharma Ltd.

Provide EV/FCFF
for Guobang Pharma Ltd.

Provide EV/IC
for Guobang Pharma Ltd.

Show me price targets
for Guobang Pharma Ltd made by professional analysts.

What are the Revenue projections
for Guobang Pharma Ltd?

How accurate were the past Revenue estimates
for Guobang Pharma Ltd?

What are the Net Income projections
for Guobang Pharma Ltd?

How accurate were the past Net Income estimates
for Guobang Pharma Ltd?

What are the EPS projections
for Guobang Pharma Ltd?

How accurate were the past EPS estimates
for Guobang Pharma Ltd?

What are the EBIT projections
for Guobang Pharma Ltd?

How accurate were the past EBIT estimates
for Guobang Pharma Ltd?

Compare the revenue forecasts
for Guobang Pharma Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Guobang Pharma Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Guobang Pharma Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Guobang Pharma Ltd compared to its peers.

Compare the P/E ratios
of Guobang Pharma Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Guobang Pharma Ltd with its peers.

Analyze the financial leverage
of Guobang Pharma Ltd compared to its main competitors.

Show all profitability ratios
for Guobang Pharma Ltd.

Provide ROE
for Guobang Pharma Ltd.

Provide ROA
for Guobang Pharma Ltd.

Provide ROIC
for Guobang Pharma Ltd.

Provide ROCE
for Guobang Pharma Ltd.

Provide Gross Margin
for Guobang Pharma Ltd.

Provide Operating Margin
for Guobang Pharma Ltd.

Provide Net Margin
for Guobang Pharma Ltd.

Provide FCF Margin
for Guobang Pharma Ltd.

Show all solvency ratios
for Guobang Pharma Ltd.

Provide D/E Ratio
for Guobang Pharma Ltd.

Provide D/A Ratio
for Guobang Pharma Ltd.

Provide Interest Coverage Ratio
for Guobang Pharma Ltd.

Provide Altman Z-Score Ratio
for Guobang Pharma Ltd.

Provide Quick Ratio
for Guobang Pharma Ltd.

Provide Current Ratio
for Guobang Pharma Ltd.

Provide Cash Ratio
for Guobang Pharma Ltd.

What is the historical Revenue growth
over the last 5 years for Guobang Pharma Ltd?

What is the historical Net Income growth
over the last 5 years for Guobang Pharma Ltd?

What is the current Free Cash Flow
of Guobang Pharma Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Guobang Pharma Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Guobang Pharma Ltd

Current Assets 5.1B
Cash & Short-Term Investments 1.6B
Receivables 1.3B
Other Current Assets 2.2B
Non-Current Assets 5B
Long-Term Investments 194.2m
PP&E 4.4B
Intangibles 354.7m
Other Non-Current Assets 17.7m
Current Liabilities 2.3B
Accounts Payable 622m
Accrued Liabilities 89.8m
Short-Term Debt 1B
Other Current Liabilities 502.6m
Non-Current Liabilities 256.1m
Long-Term Debt 230m
Other Non-Current Liabilities 26.1m
Efficiency

Earnings Waterfall
Guobang Pharma Ltd

Revenue
5.7B CNY
Cost of Revenue
-4.4B CNY
Gross Profit
1.4B CNY
Operating Expenses
-602m CNY
Operating Income
762m CNY
Other Expenses
-59.8m CNY
Net Income
702.3m CNY

Free Cash Flow Analysis
Guobang Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Guobang Pharma Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
Positive 3-Year Average ROIC
51/100
Profitability
Score

Guobang Pharma Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Guobang Pharma Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
74/100
Solvency
Score

Guobang Pharma Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Guobang Pharma Ltd

Wall Street analysts forecast Guobang Pharma Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Guobang Pharma Ltd is 24.48 CNY with a low forecast of 24.24 CNY and a high forecast of 25.2 CNY.

Lowest
Price Target
24.24 CNY
14% Upside
Average
Price Target
24.48 CNY
15% Upside
Highest
Price Target
25.2 CNY
18% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Guobang Pharma Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Guobang Pharma Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Guobang Pharma Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

11.8B CNY

Dividend Yield

1.42%

Description

Guobang Pharma Ltd. engages in the research, development, manufacturing and sale of pharmaceutical products. The company is headquartered in Shaoxing, Zhejiang and currently employs 3,326 full-time employees. The company went IPO on 2021-08-02. The firm's pharmaceutical business includes raw materials, key pharmaceutical intermediates and preparations, and its main products include azithromycin, clarithromycin, and roxithromycin cephalosporin series products. The animal health products business includes animal protection raw materials, animal protection additives and preparations. The main products of veterinary antibiotics include florfenicol, enrofloxacin series, etc., and insecticides include diclazuril and cypronamine, and reparation products include premixes, powders, granules, etc.

Contact

ZHEJIANG
Shaoxing
No. 60, Xingmei Avenue, Xinchang Provincial High-tech Industrial Park
+8657586126555
www.gbgcn.com

IPO

2021-08-02

Employees

3 326

Officers

CFO, Financial Director, Company Secretary & Director
Mr. Yuda Gong

See Also

Discover More
What is the Intrinsic Value of one Guobang Pharma Ltd stock?

The intrinsic value of one Guobang Pharma Ltd stock under the Base Case scenario is 34.07 CNY.

Is Guobang Pharma Ltd stock undervalued or overvalued?

Compared to the current market price of 21.27 CNY, Guobang Pharma Ltd is Undervalued by 38%.

Back to Top